Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) • Investment Management • Life Science |
Stages | Seed |
Investing | Canada • Israel |
iGan Partners is a growth capital firm based in Canada, focusing on empowering dynamic management teams through partnering and bringing together their own funds with affiliated co-investors. They specialize in seed investments and operate as a venture capital (VC) fund. iGan Partners has a strong emphasis on the healthcare sector, with a keen interest in leading global healthcare transformation. By investing in entrepreneurs disrupting healthcare, they commit to commercializing and scaling technological advancements in the field. The firm offers smart-capital, active support, and access to a network of industry partners and sector-specific co-investors to help portfolio companies grow and succeed. iGan Partners is involved in various industries including Software (Web Marketplace SaaS, etc.), IT & TMT, Media, BioTech, Medical Devices & Hospital Services, Real Estate & Construction, Healthcare & Wellness, Investment Management, Life Science, and other related fields. Their portfolio includes companies like MolecuLight, which has secured substantial investments to accelerate its growth in multiple regions. The team at iGan Partners positions themselves as entrepreneurs, investors, and industry experts. They have created jobs, secured multiple investments, and gained numerous patents through their work with portfolio companies. iGan's approach is highly founder-centric, as evidenced by testimonials from entrepreneurs who praise the firm's role in providing initial capital, structure, insight, and support throughout the investment rounds. Located at 60 Bloor Street West in Toronto, iGan Partners continues to be an integral player in the success of healthcare-related enterprises and innovative technologies aiming to make a significant impact on patient care and the medical industry at large.